Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach
Anusha Balla(Gachon University), Han‐Joo Maeng(Gachon University), Yoo‐Seong Jeong(Seoul National University), Yoon‐Jee Chae(Instytut Farmaceutyczny), Suk‐Jae Chung(Seoul National University), Hyojung Kim(Samsung (South Korea)), Yunjong Lee(Sungkyunkwan University)
Cited by 10
Related Papers
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
|Proceedings of the National Academy of Sciences|2011|263
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
|Proceedings of the National Academy of Sciences|2015|259